 | Zacks Investment Research Upgrades Revolution Medicines (NASDAQ:RVMD) to "Hold" marketbeat.com - March 25 at 2:55 AM |
 | Insider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) Director Sells 18,215 Shares of Stock americanbankingnews.com - April 7 at 7:32 PM |
 | Revolution Medicines, Inc. (NASDAQ:RVMD) Director Sells $1,274,656.80 in Stock americanbankingnews.com - April 7 at 7:32 PM |
 | iShares MSCI India ETF (INDA.MX) in.finance.yahoo.com - April 6 at 8:40 AM |
 | This 2020 Biotech IPO Is Poised to Break Out in 2021 finance.yahoo.com - April 2 at 7:49 AM |
 | Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021 finance.yahoo.com - March 11 at 7:59 PM |
 | Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences finance.yahoo.com - February 18 at 9:45 AM |
 | Estimating The Fair Value Of Revolution Medicines, Inc. (NASDAQ:RVMD) finance.yahoo.com - February 9 at 3:06 PM |
 | Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares finance.yahoo.com - February 8 at 6:20 PM |
 | Revolution Medicines Raises $260.9 Million In Upsized Offering finance.yahoo.com - February 4 at 1:52 PM |
|
 | Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock finance.yahoo.com - February 4 at 12:14 AM |
 | Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 5 at 9:25 AM |
 | Is RVMD A Good Stock To Buy Now? finance.yahoo.com - December 15 at 11:50 PM |
 | We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth finance.yahoo.com - November 26 at 12:37 PM |
 | Why Revolution Medicines Stock Is Trading Higher benzinga.com - November 12 at 7:57 PM |
 | Revolution Medicines EPS misses by $0.03, misses on revenue seekingalpha.com - November 12 at 9:52 AM |
 | Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress finance.yahoo.com - November 12 at 9:52 AM |
 | Revolution Medicines' RMC-4630 shows anti-tumor activity in colorectal cancer; collaborates with AstraZeneca seekingalpha.com - October 26 at 3:17 AM |
 | Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers finance.yahoo.com - October 24 at 12:45 PM |
 | Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for bloomberg.com - October 14 at 1:55 PM |
 | Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for RAS-Addicted Solid Tumors finance.yahoo.com - October 14 at 2:58 AM |
 | Revolution Medicines to present interim data from early-stage cancer study in an upcoming symposium seekingalpha.com - October 12 at 4:39 PM |
 | Revolution Medicines (RVMD) Looks Good: Stock Adds 6.9% in Session nasdaq.com - September 22 at 2:05 PM |
 | High Hopes for Amgen and Gilead at Europe’s Biggest Cancer Research Conference finance.yahoo.com - September 18 at 6:05 PM |
 | Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors finance.yahoo.com - September 16 at 1:36 PM |
 | Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference finance.yahoo.com - September 9 at 10:24 AM |
 | Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference finance.yahoo.com - September 8 at 8:15 AM |
 | Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like finance.yahoo.com - August 28 at 12:42 PM |
|
 | Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like finance.yahoo.com - August 28 at 12:42 PM |
 | Revolution Medicines, Inc. (RVMD) ca.finance.yahoo.com - August 16 at 7:22 AM |
 | Revolution Medicines Inc. barrons.com - August 16 at 7:22 AM |
 | Revolution Medicines Inc reuters.com - August 12 at 9:39 AM |
 | Revolution Medicines EPS misses by $0.10, misses on revenue seekingalpha.com - August 10 at 5:48 PM |
 | Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress finance.yahoo.com - August 10 at 7:47 AM |
 | Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares finance.yahoo.com - July 13 at 9:26 PM |
 | Revolution Medicines (RVMD) Catches Eye: Stock Jumps 10.2% finance.yahoo.com - July 13 at 10:00 AM |
 | Revolution Medicines Announces Proposed Public Offering of Common Stock finance.yahoo.com - July 6 at 8:02 PM |
 | Revolution Medicines Reports New Application of Tri-Complex Modality for “Undruggable” Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus finance.yahoo.com - June 30 at 5:47 PM |
 | Hedge Funds Are Cashing Out Of Innovative Industrial Properties, Inc. (IIPR) finance.yahoo.com - June 28 at 6:07 PM |
 | Hedge Funds Are Piling Into Avanos Medical (AVNS) finance.yahoo.com - June 28 at 6:07 PM |
 | Revolution Medicines Provides Research and Development Update for its Portfolio of Novel Targeted Cancer Therapies finance.yahoo.com - June 22 at 7:27 PM |
 | Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor finance.yahoo.com - June 22 at 9:25 AM |
 | Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510 finance.yahoo.com - June 9 at 10:07 AM |
 | Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress finance.yahoo.com - May 14 at 5:52 PM |
 | Bill.com Holdings, Inc. (BILL) Q3 2020 Earnings Call Transcript www.fool.com - May 8 at 2:23 PM |
 | Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models finance.yahoo.com - April 29 at 10:53 AM |
 | New Clinical Trial Exploring Revolution Medicines’ Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute finance.yahoo.com - March 9 at 8:20 AM |
 | Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares www.marketwatch.com - February 20 at 8:42 PM |
 | Revolution Medicines shares soar 85% in trading debut after IPO priced at top end of range finance.yahoo.com - February 20 at 10:40 AM |
 | The Funded: 7 Bay Area startups raise over $135M at week's end finance.yahoo.com - February 20 at 10:40 AM |
 | Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares finance.yahoo.com - February 20 at 10:40 AM |